Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Day One Biopharmaceuticals (DAWN) Non Operating Investment Income (2024)

Historic Non Operating Investment Income for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Q2 2024 value amounting to $108.0 million.

  • Day One Biopharmaceuticals' Non Operating Investment Income changed N/A to $108.0 million in Q2 2024 from the same period last year, while for Jun 2025 it was $108.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $108.0 million for FY2024, which is N/A changed from last year.
  • Day One Biopharmaceuticals' Non Operating Investment Income amounted to $108.0 million in Q2 2024.
  • In the past 5 years, Day One Biopharmaceuticals' Non Operating Investment Income registered a high of $108.0 million during Q2 2024, and its lowest value of $108.0 million during Q2 2024.